BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report)’s share price fell 2.5% during trading on Tuesday . The company traded as low as $0.2160 and last traded at $0.2160. Approximately 9,557 shares traded hands during trading, a decline of 88% from the average daily volume of 78,262 shares. The stock had previously closed at $0.2216.
BetterLife Pharma Price Performance
The stock has a 50-day moving average of $0.20 and a 200 day moving average of $0.10.
BetterLife Pharma Company Profile
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders.
Further Reading
- Five stocks we like better than BetterLife Pharma
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
- Uncle Sam’s Quantum Leap: Feds Fund a $300M Quantum Supercycle
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
